Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Bezemer, Geert ^a   Van Gool, Arthur R ^a,b   Verheij Hart, Elke ^a   Hansen, Bettina E ^a   Lurie, Yoav ^c   Esteban, Juan I ^d   Lagging, Martin ^e   Negro, Francesco ^f   Zeuzem, Stefan ^g   Ferrari, Carlo ^h   Pawlotsky, Jean Michel ⁱ   Neumann, Avidan U ^j   Schalm, Solko W ^a   de Knegt, Robert J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Organization for Mental Health   (Netherlands)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^h UNIVERSITY HOSPITAL OF PARMA   (Italy)

ⁱ HENRI MONDOR HOSPITAL   (France)

^j BAR ILAN UNIVERSITY   (Israel)

more..

Author keywords

Health related quality of life; Hepatitis C; Peginterferon

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; RECOMBINANT PROTEIN;

AGE; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SHORT FORM 36; TREATMENT DURATION; TREATMENT OUTCOME; ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; EUROPE; HEALTH SURVEY; HOSPITALIZATION; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHASE 3 CLINICAL TRIAL; SEXUAL DEVELOPMENT;

ADULT; AGE FACTORS; AGED; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; HEALTH SURVEYS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYETHYLENE GLYCOLS; QUALITY OF LIFE; RECOMBINANT PROTEINS; RIBAVIRIN; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 84857797505     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-11     Document Type: Article

References (23)

1. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998, 27:209-212. 10.1002/hep.510270132, 9425939.
2. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005, 41:790-800. 10.1002/hep.20659, 15791608.
3. Castera L, Constant A, Bernard PH, de Ledinghen V, Couzigou P. Psychological impact of chronic hepatitis C: comparison with other stressful life events and chronic diseases. World J Gastroenterol 2006, 12:1545-1550.
4. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999, 30:1299-1301. 10.1002/hep.510300504, 10534353.
5. Niederau C, Bemba G, Kautz A. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany--socioeconomic aspects in hepatitis C]. Z Gastroenterol 2006, 44:305-317. 10.1055/s-2006-926510, 16625459.
6. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56. 10.1038/nrn2297, 2919277, 18073775.
7. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen JC, Ahl B, Manns MP, Boker KW. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004, 41:845-851. 10.1016/j.jhep.2004.07.022, 15519659.
8. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999, 29:264-270. 10.1002/hep.510290124, 9862876.
9. Ware JE, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. Hepatology 1999, 30:550-555. The Interventional Therapy Group, 10.1002/hep.510300203, 10421667.
10. McHutchison JG, Ware JE, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, Neary MP, . Hepatitis Interventional Therapy Group The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001, 34:140-147. Hepatitis Interventional Therapy Group.
11. Hassanein T, Cooksley G, Sulkowski M, Smith C, Marinos G, Lai MY, Pastore G, trejo-Estrada R, Horta E, Vale A, Wintfield N, green J. The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. J Hepatol 2004, 40:675-681. 10.1016/j.jhep.2003.12.014, 15030985.
12. Zeuzem S, Pawlotsky JM, Lukasiewicz E, von Wagner M, Goulis I, Lurie Y, Gianfranco E, Vrolijk JM, Esteban JI, Hezode C, Lagging M, Negro F, Soulier A, Verheij-Hart E, Hansen B, Tal R, Ferrari C, Schalm SW, Neumann AU, . DITTO-HCV Study Group International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. J Hepatol 2005, 43:250-257. 10.1016/j.jhep.2005.05.016, 16082736, DITTO-HCV Study Group.
13. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995, 33(Suppl):AS264-79.
14. Wessely S, Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med 2002, 32:1-10.
15. Kallman J, O'Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 2007, 52:2531-2539. 10.1007/s10620-006-9708-x, 17406828.
16. Ware JE, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. 1993, Boston, MA: New England Medical Center, The Health Institute.
17. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998, 51:1055-1068. 10.1016/S0895-4356(98)00097-3, 9817123.
18. Lewin-Epstein N, Sagiv-Schifter T, Shabtai EL, Shmueli A. Validation of the 36-item short-form Health Survey (Hebrew version) in the adult population of Israel. Med Care 1998, 36:1361-1370. 10.1097/00005650-199809000-00008, 9749659.
19. Sulkowski MS, Wasserman R, Brooks L, Ball L, Gish R. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection. J Viral Hepat 2004, 11:243-250. 10.1111/j.1365-2893.2004.00490.x, 15117326.
20. Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH, . PROACTIVE Study Group Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy. Hepatology 2004, 40:1450-1458. 10.1002/hep.20482, 15565613, PROACTIVE Study Group.
21. Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR, . HALT-C Trial Group Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol 2007, 46:420-431. 10.1016/j.jhep.2006.10.009, 1995129, 17196293, HALT-C Trial Group.
22. Wagner AK, Gandek B, Aaronson NK, Acquadro C, Alonso J, Apolone G, Bullinger M, Bjorner J, Fukuhara S, Kaasa S, Leplege A, Sullivan M, Waud-Dauphinee S, Ware JE. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:925-932. 10.1016/S0895-4356(98)00083-3, 9817109.
23. Bullinger M, Alonso J, Apolone G, Leplege A, Sullivan M, Wood-Dauphinee S, Gandek B, Wagner A, Aaronson N, Bech P, Fukuhara S, Kasa S, Ware JE. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:913-923. 10.1016/S0895-4356(98)00082-1, 9817108.